180 Life Sciences CEO (ATNF) Jim Woody With A Company Overview

180 Life Sciences: ATNF CEO, Jim Woody, says that the company is focused on drug development that fulfills unmet needs in inflammatory diseases. It seeks to develop novel drugs addressing separate areas of inflammation. What is next for 180 Life Sciences and how will the stock price be affected?

The Watch List

03 May 2021

ON AIR
7:00 am
Futures

Get Market Minute

Daily insights for every investor

FOLLOW US

180 Life Sciences CEO (ATNF) Jim Woody With A Company Overview

180 Life Sciences: ATNF CEO, Jim Woody, says that the company is focused on drug development that fulfills unmet needs in inflammatory diseases. It seeks to develop novel drugs addressing separate areas of inflammation. What is next for 180 Life Sciences and how will the stock price be affected?

The Watch List

03 May 2021